Market Size (2017)
2017
—
Vertical: HealthcareBase Year: 201912 Sections
Market Size (2017)
2017
—
Projected (2027)
2027
—
CAGR (2017–2027)
N/A
Key Players
106+
Global Blood Transfusion Diagnostics market is expected to grow at ~7.0% CAGR during the forecast period, 2020-2027
XX
Global Blood Transfusion Diagnostics Market by Product
XX
Global Blood Transfusion Diagnostics Market by Application
XX
Global Blood Transfusion Diagnostics Market by End User
XX
Global Blood Transfusion Diagnostics Market by region
Blood Transfusion Diagnostics Market is a key focus area for market intelligence and strategic research.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansAnalysis of Blood Transfusion Diagnostics Market from 2017 to 2027. Covers North America, Europe, Asia Pacific, Rest of the World.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistics agencies, and paid databases. This information creates a base for the study. The information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analyzed to extract crisp data points which currently affect or are likely to affect the industry during the forecast period. After analyzing the information, a proprietary statistical tool is used for market estimation and forecast, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for the forecast period.
After estimating the market sizes and estimates, the numbers are verified with industry participants and key opinion leaders. The wide network of industry participants add value to the research and verify the numbers and estimates provided in the study. At the last stage of the research process, a final report is prepared, which is then published on different websites as well as distributed through various channels. The below figure contains the different stages of the research process to produce the report.
Data Mining
Data mining is an extensive part of our research process. It involves the procurement of market data and related information from different verified and credible sources. This step helps to obtain raw information about the components of the industry and their source, the monetary process for different end uses, the pool of market participants, and the nature of the industry and scope of the study. The data mining stage comprises both primary and secondary sources of information.
Secondary Research
In the secondary research process, various sources are used to identify and gather industry trends and information for the research process. We at MRFR have access to some of the most diversified and extensive paid databases, which give us the most accurate data/ information on markets sizes, components, and pricing. Mentioned below is a detailed list of Sources that have been used for this study. Please note that this list is not limited to the names as mentioned; we also access other data Sources depending on the need.
Primary Research
In the primary research process, in-depth primary interviews are conducted with the CXOs to understand the market share, customer base, pricing strategies, channel partners, and other necessary information. Besides, in-depth primary interviews are conducted with the CXOs of vendors, channel partners, and others to validate the supply-side information. In addition, various key industry participants from both the supply and demand side are interviewed to obtain qualitative and quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (SMEs), industry consultants, and C-level executives of major companies, are conducted to obtain critical qualitative and quantitative information pertaining to the market, as well as to assess the prospects for market growth during the forecast period. Detailed information on these primary respondents is mentioned below.
PRIMARY INTERVIEWS AND INFORMATIONGATHERING PROCESS
Breakdown of Primary Respondents
Forecasting Techniques
We at MRFR follow an extensive process for arriving at market estimations, which involves the use of multiple forecasting techniques as mentioned below.
Research Methodology for Market size estimation
Understanding the market in terms of valuation is a crucial task. This becomes significantly important while investing in and choosing the correct business opportunities. In this regard, we at MRFR undertake two market sizing approaches simultaneously, namely, the top-down and bottom-up approaches. In this step, we assess different data points, numeric attributes, information, and industry trends to arrive at the estimates and forecast values for the coming years. We use different mathematical models to estimate the market sizes of different economies and segments, each of which is further summed up to define the total market.
We at MRFR employ a proprietary statistical tool for market estimations, which helps us to arrive at market size estimates and forecasts for different markets and industries.
Bottom-UP approach
In the bottom-up approach, the revenue of key companies and their shares in the market are assessed to deduce the market size. More than 25 key players operating in the Global Blood Transfusion Diagnostics market are studied. The segmental revenue of each player is analyzed and the size for the Global Blood Transfusion Diagnostics market is extracted from the segmental/product revenue with the help of secondary and primary research. The extracted size for the market is then validated with industry experts and partner consultants. This derived market size contributes to around 65%–70% of the total global market share in terms of revenue for the Global Blood Transfusion Diagnostics market. Using the data triangulation method, the overall global market size is estimated.
Top-Down approach
The overall market size is then used in the top-down procedure to estimate the size of the other sub-markets with the help of percentage splits of the market segments from secondary and primary research. The demand-side analysis is conducted, in which the expenditure of major industry players in each region is studied.
The countries considered in the scope of the Global Blood Transfusion Diagnostics market are the US, Canada, Mexico, the UK, Germany, France, Italy, Spain, China, Japan, India, Australia & New Zealand, South Africa, Egypt, Nigeria, Saudi Arabia, Qatar, the UAE, Bahrain, Kuwait, and Oman, Brazil, Argentina, Chile, and others. However, the number of countries varies according to the market. The figure below depicts the process of market estimation using independent tools employed by our analysts to arrive at the sizing of the market.
As a part of the market engineering, the both top-down and bottom-up approaches are utilized along with data triangulation models to derive and verify the market sizes and forecast over the coming years.
Data Triangulation
After arriving at the overall market sizes, the total market is divided into several segments and sub-segments. Again, the market breakdown and data triangulation procedures are implemented, wherever applicable, to complete the overall market engineering process and gather the exact statistics for all segments and sub-segments. The data is triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size is validated using the top-down and bottom-up approaches.
Validation
Validation is the most important stage of the report making process. Validation via an intricately designed feedback process helps us finalize the sizing estimates and forecast for the final collation. Extensive primary research is performed to verify the information. This includes telephonic and personal interviews, e-mails, feedback forms, questionnaires, and polling options/answers with a group of relevant industry participants. Validation helps to duly check the authenticity of the key industry trends, market dynamics, company market share, different business models, and conclusions.
Base Year
2019
Historical Period
2017 – 2019
Forecast Period
2019 – 2027
Primary Interviews
150+
Historical data (2017–2019) and forecast period (2019–2027)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
See plans for professionals or small and medium businesses.

Analytical insights on Blood Transfusion Diagnostics Market covering market dynamics, competitive landscape, and strategic outlook.
Blood Transfusion Diagnostics Market represents a significant market opportunity with multiple growth drivers across regions and segments.
The Blood Transfusion Diagnostics Market market encompasses 4 key regions and multiple market segments, with the study period spanning 2017 to 2027.
The market is segmented across multiple dimensions, with detailed breakdowns available by component, region, and application type to support strategic planning and investment decisions.
This report profiles 106 key companies operating in the Blood Transfusion Diagnostics Market market, covering market positioning, product portfolios, and recent developments.
Leading players include F. Hoffmann-La Roche AG, ABBOTT LABORATORIES, Bio-Rad Laboratories, Inc. , Ortho Clinical Diagnostics , Immucor, Inc., and 101 others.
Impact on cost of raw materials and products
Impact on availability of products
Impact on production of major manufacturers
Impact on trade (import/export)
Profiles of 106 companies operating in the Blood Transfusion Diagnostics Market market, including revenue, employee count, and market positioning where available.
Showing 106 of 106 companies
DIASORIN S.P.A.
Company Headquarters: Saluggia, Italy Founded: 2000 Workforce: ~ 1,971 Company Working: DIASORIN S.P.A. is an Italian multinational group and a global leader in the in-vitro diagnostics market. It is one of the listed companies on MTA (Mercato Telematico Azionario) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A. It provides its services to hospitals, private testing laboratories of immunodiagnostics, and molecular diagnostics. It is one of the leading healthcare companies that provide services to about 4000 US hospitals and health systems and approximately 165,000 other providers and healthcare organizations. It provides services at lower costs to hospitals and other pharmaceutical industries.
Ortho Clinical Diagnostics
Company Headquarters: Raritan, New Jersey, US Founded: 1939 Workforce: ~ 5,400 Company Working: Ortho Clinical Diagnostics is a global leader of in-vitro diagnostic services. It provides high-quality products and services to clinical laboratory and immunohematology communities. It provides its services to hospitals, hospital networks, blood banks, and labs in more than 120 countries. It provides testing technologies, automation, information management, and interpretation tools to clinical laboratories around the world.
ABBOTT LABORATORIES
Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin-top:0cm; mso-para-margin-right:0cm; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0cm; line-height:107%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Roboto Condensed"; mso-ascii-font-family:"Roboto Condensed"; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:"Roboto Condensed"; mso-hansi-theme-font:minor-latin; mso-ansi-language:EN-US; mso-fareast-language:EN-US;} Company Headquarters: Illinois, US Founded: 1888 Workforce: ~103,000 Company Working: Abbott Laboratories is engaged in the research, manufacture, and sale of branded generic pharmaceuticals, nutritional products, medical devices, and diagnostics. The company operates in the US, the Netherlands, Germany, Japan, Italy, France, Canada, the UK, and Spain. The four major segments of the company are nutritionals, diagnostics, established pharmaceutical products, and cardiovascular & neuromodulation, and others. The nutritional segment of the company includes a broad line of pediatric and adult nutritional products. The nutritionals segment also includes nutritional products used in enteral feeding in healthcare institutions.
BAG Health Care GmbH
BAG Health Care GmbH — Healthcare
Quotient Limited
Quotient Limited — Healthcare
F. Hoffmann-La Roche AG
F. Hoffmann-La Roche AG — Healthcare
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Blood Transfusion Diagnostics Market